Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report published by Infinium Global Research on continuous renal replacement therapy (CRRT) market provides an in-depth analysis of segments and sub-segments in the global as well as regional continuous renal replacement therapy market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional continuous renal replacement therapy market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global continuous renal replacement therapy market. According to the report, the global continuous renal replacement therapy market is projected to grow at a CAGR of 5.25% over the forecast period of 2018-2024.
Continuous renal replacement therapy is a form of dialysis therapy that replaces the normal blood filtering function of the kidneys. Renal treatment is for critically ill and hemodynamically unstable patients in the intensive care unit. Several ways are available for filtration of blood such as hemodiafiltration, hemofiltration, and hemodialysis. Continuous renal replacement therapy is an alternative renal replacement therapy for the removal of wastes and excess plasma water in critically ill patients. Benefits offered by continuous renal replacement therapy are the maintenance of fluid balance, maintains electrolyte balance, prevent further damage to the kidney tissue.
The increasing occurrence of hypertension and diabetic patients drives the growth of continuous renal replacement therapy market. The occurrence of both hypertension and diabetic patients increases the risk of kidney diseases. Furthermore, the growing aging population coupled with a number of patients admitted to the intensive care unit that requires continuous renal replacement therapy for dialysis boosts the growth of continuous renal replacement therapy market. Moreover, growing worldwide incidence of acute kidney ailments propels the demand for continuous renal replacement therapy. Technological advancements and benefits offered by continuous renal replacement therapy fuel the growth of continuous renal replacement therapy market. However, complications related to therapy affects preferentiality among geriatric population hinders the growth of continuous renal replacement therapy market. High cost associated with CRRT may hamper the growth of continuous renal replacement therapy market. Moreover, the growing use of continuous renal replacement therapy for dialysis expected to provide beneficial opportunities for continuous renal replacement therapy market.
Based on region, Europe dominates the continuous renal replacement therapy market owing to the increasing prevalence of hypertension and diabetic patients. Growing incidences of acute kidney ailments boost the growth of continuous renal replacement therapy in the region. The Asia-Pacific is expected to fuel the growth of continuous renal replacement therapy market. Improved healthcare expenditure and increasing adoption of continuous renal replacement therapy in the Asia-Pacific region propel the growth of continuous renal replacement therapy market.
The report on global continuous renal replacement therapy market covers segments such as product, therapy, modality, and end-user. On the basis of product, the sub-markets include disposables, systems, and dialysates and replacement fluids. On the basis of therapy, the sub-markets include non-renal, and renal. On the basis of modality, the sub-markets include slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), and continuous venovenous hemodiafiltration (CVVHDF). On the basis of end-user, the sub-markets include hospitals, dialysis clinics, homes, and others.
The report provides profiles of the companies in the market such as INFOMED SA, Baxter International Inc, Toray Medical Co., LTD, Asahi Kasei Medical Co., Ltd., NIKKISO CO., LTD., B. Braun Melsungen AG, Nipro Corporation, Bellco (Medtronic plc.), NxStage Medical, Inc., and Fresenius Medical Care AG & Co. KGaA.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of continuous renal replacement therapy market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.
Please Choose One of them.